Latest Insider Transactions at Artiva Biotherapeutics, Inc. (RTVA)
This section provides a real-time view of insider transactions for Artiva Biotherapeutics, Inc. (RTVA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Artiva Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Artiva Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 22
2024
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. |
BUY
Other acquisition or disposition
|
Direct |
49,019
+20.16%
|
$490,190
$10.2 P/Share
|
|
Jul 22
2024
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. |
BUY
Conversion of derivative security
|
Direct |
145,089
+50.0%
|
-
|
|
Jul 22
2024
|
Yong Jun Huh |
BUY
Open market or private purchase
|
Indirect |
2,083,332
+29.18%
|
$24,999,984
$12.0 P/Share
|
|
Jul 22
2024
|
Yong Jun Huh |
BUY
Other acquisition or disposition
|
Indirect |
550,433
+19.25%
|
$5,504,330
$10.2 P/Share
|
|
Jul 22
2024
|
Yong Jun Huh |
BUY
Conversion of derivative security
|
Indirect |
1,352,252
+26.17%
|
-
|
|
Jul 22
2024
|
Fred Aslan President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
228,905
+50.0%
|
-
|